SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Jubilant Pharmova Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
530019 INE700A01033 146.9008161 JUBLPHARMA 0.74 10,721.69 0 0 1
Quarters :
ParticularsDec 2023(Rs.Cr)Sep 2023(Rs.Cr)Jun 2023(Rs.Cr)
Gross Sales170.20179.40203.90
Other Operating Income5.006.9013.50
Other Income 19.0018.4015.90
Total Income194.20204.70233.30
Total Expenditure 175.90185.50213.20
PBIDT18.3019.2020.10
Interest 8.307.106.40
PBDT10.0012.1013.70
Depreciation12.3011.9011.40
Tax-0.400.000.40
Fringe Benefit Tax0.000.000.00
Deferred Tax0.500.600.00
Reported Profit After Tax-2.40-0.401.90
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-2.40-0.401.90
    
EPS (Unit Curr.)-0.15-0.030.12
EPS (Adj) (Unit Curr.)-0.15-0.030.12
Calculated EPS (Unit Curr.)-0.15-0.030.12
Calculated EPS (Adj) (Unit Curr.)-0.15-0.030.12
Calculated EPS (Ann.) (Unit Curr.)-0.60-0.100.48
Calculated EPS (Adj) (Ann.) (Unit Curr.)-0.60-0.100.48
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity15.9015.9015.90
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)10.7510.709.86
PBDTM(%)5.886.746.72
PATM(%)-1.41-0.220.93